• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall GlideScope Video Laryngoscope

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall GlideScope Video Laryngoscope see related information
Date Initiated by Firm March 31, 2019
Create Date March 11, 2020
Recall Status1 Terminated 3 on December 14, 2021
Recall Number Z-1471-2020
Recall Event ID 84329
Product Classification Laryngoscope, rigid - Product Code CCW
Product GlideScope Video Laryngoscope, Operations & Maintenance Manual, 0900-4940 REV 03
Code Information GlideScope Video Laryngoscope Operation and Maintenance Manual Catalog #: 0900-4940 Product can be further identified as In-Service USB 0901-0197  Affected Revision  Rev. 00 distributed January 1, 2019 February 28, 2019  GlideScope Video Laryngoscope Product Serial Numbers are included in Appendix A: Domestic and Foreign Consignee List (in Associated Documents)
Recalling Firm/
Manufacturer
Verathon, Inc.
20001 N Creek Pkwy
Bothell WA 98011-8218
For Additional Information Contact
425-892-0230
Manufacturer Reason
for Recall
A typographical error in the Operations & Maintenance Manual incorrectly identifies the use of low level disinfection for the reusable video laryngoscope, specifically for the Titanium Blades.
FDA Determined
Cause 2
Error in labeling
Action On 03/31/2019 the firm communicated a "Field Safety Notice Medical Device Recall" letter to customers via FedEx informing them the firm has identified that the disinfection levels outlined in Table 9 (Table 9. System Risk Classification) on page 23 of the Operations & Maintenance Manual (OMM) incorrectly indicates (X in the table cell) that low level disinfection is the minimum disinfection level required for the reusable Titanium video laryngoscope. The correct reference should be an X in the table cell indicating that high-level disinfection is required. The error in Table 9 contradicts the other references and warnings in the OMM that correctly state The reusable Titanium video laryngoscope is considered a semicritical device intended to contact the airway. It must be thoroughly cleaned and undergo high-level disinfection after each use (pages 6, 21, and 34 of the OMM). Customers are instructed to: 1) Determine whether their facility currently has a copy of the In-Service USB (0901-0197) or the GlideScope Video Laryngoscopes Operations and Maintenance Manual 0900-4940 Rev.00 (OMM). If so, dispose of the In-Service USB as well as any printed or saved copies of the OMM. 2) Download and retain the updated GlideScope¿ Video Laryngoscopes Operations and Maintenance Manual 0900-4940 Rev. 01 from the Product Documentation site: https://www.verathon.com/productdocumentation/ 3) Review the disinfection of any reusable Titanium video laryngoscopes completed from January 01, 2019 - February 28, 2019 to ensure that high-level disinfection was completed. High level disinfect any units that were or may have been processed using low-level disinfection. 4) Fill out the attached Recall Response Form and return it by email to CSNotifications@verathon.com. Some facilities may not currently have copies of the In-Service USB (0901-0197) or the OMM subject to this Field Safety Notice (e.g., because they did not retain the In-Service USB or print or save a copy
Quantity in Commerce 239 manuals
Distribution US: RI, IL, FL, SD, NY, MD, CA, OH, LA, AZ, GA, WA, OK, NC, AL, PA, TN, NJ, NV, MI, OR, TX, NM, VA, UT, NE, WI, CO, AR, MN, CT, ND, and KS. OUS: Canada
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-